AA
LHDX

AlphaCentric Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

AlphaCentric Advisors’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-320,200
Closed -$339K – 223
2022
Q3 		$339K Buy
+320,200
New +$729K 0.35% 72
2021
Q2 		– Sell
-17,000
Closed -$206K – 248
2021
Q1 		$206K Buy
+17,000
New +$337K 0.07% 93

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $2.57B AUM
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaCentric Advisors's LHDX Position: Q4 2022 in Review

AlphaCentric Advisors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q4 2022, closing a stake of 320,200 shares — an estimated $339K sold.

AlphaCentric Advisors first reported a position in LHDX in Q1 2021 and held it in 2 quarters. The position peaked at $339K in Q3 2022. 29 funds tracked by Wall St. Rank hold LHDX as of Q4 2022.

  • AlphaCentric Advisors reported no remaining Lucira Health, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • AlphaCentric Advisors sold 320,200 Lucira Health, Inc. Common Stock shares in Q4 2022, an estimated $339K.
  • AlphaCentric Advisors first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • AlphaCentric Advisors's Lucira Health, Inc. Common Stock position peaked at $339K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q4 2022.

Based on AlphaCentric Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.